RF Ablation and Probe Kit for pain relief and palliative treatment of metastatic malignant lesions involving bone
In the European Union, this technology is intended for use for ablation of benign bone tumors such as osteoid osteoma and palliative treatment by ablation of metastatic malignant lesions involving bone, including the vertebral body. In Canada, the technology is intended for use for radiofrequency (RF) heat lesion procedures for relief of pain, for ablation of benign bone tumors such as osteoid osteoma, and for palliative treatment of ablation of metastatic malignant lesions involving bone, including the vertebral body. In the US, this technology is intended for use for RF heat lesion procedures for relief of pain and for palliative treatment in spinal procedures by ablation of metastatic malignant lesions in a bertebral body in patients who have failed or are not candidates for standard pain therapy.
在欧盟,此技术用于良性骨肿瘤(骨样骨瘤)的消融术治疗和骨相关转移性恶性病变消融术后的舒减疗法(包括椎体)。在加拿大,此技术用于射频热损伤程序来缓解疼痛，良性骨肿瘤(骨样骨瘤)的消融术治疗和骨相关转移性恶性病变消融术后的舒减疗法(包括椎体)。在美国，此技术用于射频热损伤程序来缓解疼痛，对患者在椎体转移性恶性病变消融术后无法或不适合使用传统疼痛疗法时使用脊椎程序的舒减疗法。Clinical Applications: Bone tumors, pain relief and palliative treatment of metastatic malignant lesion.
临床应用: 骨瘤，转移性恶性病变的疼痛缓解和舒减疗法
Stage: Currently has CE mark and patents for IP.
阶段: 有CE认证和专利授权
技术售让
生物技术/制药/医疗
药械组合
